BioCentury
ARTICLE | Clinical News

Theratope: Phase III

June 23, 2003 7:00 AM UTC

In a double-blind, international Phase III trial in 1,030 patients, Theratope did not meet the primary endpoints of improving time to disease progression and overall survival. BRA said that in a pre-s...